Validation and compliance of a home monitoring device in pregnancy: microlife WatchBP home.
Hypertens Pregnancy
; 28(3): 348-59, 2009.
Article
em En
| MEDLINE
| ID: mdl-19263287
ABSTRACT
OBJECTIVE:
To assess the accuracy and patient compliance in using a novel home blood pressure monitoring device in high-risk pregnancy.METHODS:
Device accuracy was assessed according to the British Hypertension Society protocol in 45 pregnant women, including 15 with preeclampsia. Twenty-one high-risk pregnant women used the device in addition to their antenatal care.RESULTS:
The device achieved a mean difference +/- SD of 0.4 +/- 7.3/-0.4 +/- 5.5 mmHg (pregnancy) and -2.6 +/- 7.0/0.8 +/- 4.4 mmHg (preeclampsia) for systolic/diastolic pressure. Eighty-one percent of women did at least 6 measurements/day and all women did at least 2 measurements/week.CONCLUSION:
The Microlife WatchBP Home is accurate for use in pregnancy and increases surveillance in compliant patients.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Pressão Sanguínea
/
Monitorização Ambulatorial da Pressão Arterial
Limite:
Adult
/
Female
/
Humans
/
Pregnancy
Idioma:
En
Ano de publicação:
2009
Tipo de documento:
Article